Robin Kate Kelley - Publications, H-index & Citations

Back

Robin Kate Kelley

university of california san francisco

94H-index

509Paper Count

7.9WCitation Count

Published Papers 117

Publication Date

Systemic therapy for HCC: Doublets, triplets and beyond

Journal of Hepatology

IF33

2026-07-02

OAAI

Arndt Vogel; Robin Kate Kelley

Save

Hallmarks of liver cancer: Therapeutic implications

Cell

IF42.5

2026-04-16

OAAI

Josep M. Llovet; Roser Pinyol; Silvia Affo; Mark Yarchoan; Gregory J. Gores; Robin Kate Kelley; Scott W. Lowe; Daniela Sia; Augusto Villanueva

Save

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses

Hepatology

IF15.8

2026-02-01

PREAI

Han, Younghun; Byun, Jinyoung; Vanlith, Caitlin J.; Cooley, Matthew A.; Shaw, Vikram R.; Hatia, Rikita I.; Ahmed, Fowsiyo Y.; Giama, Nasra H.; Ali, Hawa M.; Campbell, Nellie A.; Hassan, Mohamed; Andersen, Jesper B.; Ankoma-Sey, Victor; Banales, Jesus M.; Bujanda, Luis; Bathe, Oliver F.; Bekaii-Saab, Tanios S.; Borad, Mitesh J.; Bjorkstrom, Niklas K.; Chan, Carlos H. F.; Cleary, Sean P.; Cornillet, Martin; Folseraas, Trine; Galle, Peter R.; Genkinger, Jeanine M.; MacInnis, Robert J.; Gores, Gregory J.; Goyal, Lipika; Houlston, Richard S.; Ilyas, Sumera I.; Javle, Milind; Johansen, Julia S.; Christensen, Troels D.; Kamath, Ashwin S.; Kelley, Robin Kate; Khan, Shahid A.; Kim, Richard D.; Kwee, Sandi A.; Lamarca, Angela; Lammert, Frank; Larusso, Nicholas F.; Lindsey, Stacie; Macias, Rocio I. R.; Malhi, Harmeet; Patel, Tushar C.; Permuth, Jennifer B.; Reeves, Helen L.; Rossi, Stephen; Sanchez, William; Smoot, Rory L.; Swerdlow, Anthony J.; Tran Cao, Hop S.; Valle, Juan W.; Weinmann, Arndt; Weinmann-Menke, Julia; Wong, Linda L.; Zhang, Xuehong; Zimmer, Vincent; Zhu, Andrew X.; Lazaridis, Konstantinos N.; Juran, Brian D.; Jalal, Prasun; Knox, Jennifer J.; Hutchinson, Amy; Hicks, Belynda; Koshiol, Jill E.; Chanock, Stephen J.; Hassan, Manal M.; Amos, Christopher I.; McGlynn, Katherine A.; Roberts, Lewis R.

Save

Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials

Cancer

IF5.1

2026-01-01

OAAI

Saj, Fen; Namayanja, Felicity K.; Xiao, Lianchun; Borad, Mitesh J.; Kelley, Robin Kate; Goyal, Lipika; Azad, Nilofer S.; Bachini, Melinda; Lindsey, Stacie; Pant, Shubham; Valle, Juan W.; Fashoyin-aje, Lola A.; Javle, Milind

Save

Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis

Liver Cancer

IF9.1

2025-12-01

OAAI

Chan, Stephen Lam; Kudo, Masatoshi; Sangro, Bruno; Kelley, Robin Kate; Kim, Jee Hyun; Pham, Binh; Hong, Jung Yong; Waldschmidt, Dirk-Thomas; Marino, Donatella; Lee, Jie Xin Joycelyn; Gerolami, Rene; Burgoyne, Adam M.; Li, Qiao; Nakamura, Hitomi; Sun, Peng; Baur, Boris; Rimassa, Lorenza

Save

Impact of LEAP-012 and EMERALD-1 in the Management of HCC

JHEP Reports

IF7.5

2025-11-06

OAAI

Amit Singal; Kirema Garcia-Reyes; Robin K. Kelley; Edward Kim

Save

BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update

Journal of Hepatology

IF33

2025-10-27

PREAI

Maria Reig; Marco Sanduzzi-Zamparelli; Alejandro Forner; Jordi Rimola; Joana Ferrer-Fàbrega; Marta Burrel; Ángeles Garcia-Criado; Alba Díaz; Neus Llarch; Gemma Iserte; Meritxell Mollà; Robin K. Kelley; Peter R. Galle; Vincenzo Mazzaferro; Riad Salem; Bruno Sangro; Amit Singal; Arndt Vogel; Ted K. Yanagihara; Carmen Ayuso; Ferran Torres; Jordi Bruix

Save

Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits

International Journal of Cancer

IF4.7

2025-09-27

OAAI

Younghun Han; Vikram R. Shaw; Jinyoung Byun; Aaron P. Thrift; Catherine Zhu; Donghui Li; Rikita I. Hatia; Robin Kate Kelley; Sean P. Cleary; Anna S. Lok; Paige M. Bracci; Jennifer B. Permuth; Roxana Bucur; Jennifer Knox; Jian-Min Yuan; Amit G. Singal; Prasun K. Jalal; R. Mark Ghobrial; Yuko Kono; Dimpy P. Shah; Mindie H. Nguyen; Neehar D. Parikh; Richard Kim; Hui-Chen Wu; Hashem El-Serag; Ping Chang; Yun Shin Chun; Jian Gu; Chad Huff; Asif Rashid; Lu-Yu Hwang; Alison P. Klein; Saira A. Khaderi; Ahmed O. Kaseb; Kathrine A. McGlynn; Lewis R. Roberts; Manal M. Hassan; Christopher I. Amos

Save

The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment

lancet

IF0

2025-07-28

PREAI

Stephen Lam Chan; Hui-Chuan Sun; Yang Xu; Hongmei Zeng; Hashem B El-Serag; Jeong Min Lee; Myron E Schwartz; Richard S Finn; Jinsil Seong; Xin Wei Wang; Valérie Paradis; Ghassan K Abou-Alfa; Lorenza Rimassa; Jia-Horng Kao; Bo-Heng Zhang; Josep M Llovet; Jordi Bruix; Terry Cheuk-Fung Yip; Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Landon L Chan; Man-Qi Liu; Qiang Gao; Feng Shen; Robin Kate Kelley; Ann-Lii Cheng; Masayuki Kurosaki; Hidenori Toyoda; Wei-Xia Chen; Takamichi Murakami; Ping Liang; Jessica Zucman-Rossi; Yasunori Minami; Shiro Miyayama; Kui Wang; Kwan Man; Kiyoshi Hasegawa; Qiu Li; Kaoru Tsuchiya; Li Xu; Valerie Chew; Pierce Chow; Yujin Hoshida; Amaia Lujambio; Irene Oi-Lin Ng; Michiie Sakamoto; Young Nyun Park; Thomas Yau; Masatoshi Kudo; Jia Fan; Jian Zhou

Save

Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC

Journal of Hepatology

IF33

2025-04-11

OAAI

Lorenza Rimassa; Stephen L. Chan; Bruno Sangro; George Lau; Masatoshi Kudo; Maria Reig; Valeriy Breder; Min-Hee Ryu; Yuriy Ostapenko; Wattana Sukeepaisarnjaroen; Maria Varela; David Tougeron; Oxana V. Crysler; Mohamed Bouattour; Tu Van Dao; Vincent C. Tam; Adilson Faccio; Junji Furuse; Long-Bin Jeng; Yoon Koo Kang; Robin K. Kelley; Michael J. Paskow; Di Ran; Ioannis Xynos; John F. Kurland; Alejandra Negro; Ghassan K. Abou-Alfa

Save

Five-year overall survival (OS) and OS by baseline liver function from the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Kudo, M.; Rimassa, L.; Chan, S. L.; Sangro, B.; Lau, G.; Breder, V. V.; Varela, M.; Crysler, O. V.; Bouattour, M.; Dao, V. T.; Faccio, A.; Furuse, J.; Jeng, L-B.; Kang, Y-K.; Kelley, R. K.; Paskow, M. J.; Makowsky, M.; Ran, D.; Negro, A.; Abou-Alfa, G. K.

Save

A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

OAAI

Goyal, L.; DiToro, D.; Facchinetti, F.; Martin, E. E.; Peng, P.; Baiev, I.; Iyer, R.; Maurer, J.; Reyes, S.; Zhang, K.; Majeed, U.; Berchuck, J. E.; Chen, C. T.; Walmsley, C.; Pinto, C.; Vasseur, D.; Gordan, J. D.; Mody, K.; Borad, M.; Karasic, T.; Damjanov, N.; Danysh, B. P.; Wehrenberg-Klee, E.; Kambadakone, A. R.; Saha, S. K.; Hoffman, I. D.; Nelson, K. J.; Iyer, S.; Qiang, X.; Sun, C.; Wang, H.; Li, L.; Javle, M.; Lin, B.; Harris, W.; Zhu, A. X.; Cleary, J. M.; Flaherty, K. T.; Harris, T.; Shroff, R. T.; Leshchiner, I.; Parida, L.; Kelley, R. K.; Fan, J.; Stone, J. R.; Uboha, N. V.; Hirai, H.; Sootome, H.; Wu, F.; Bensen, D. C.; Hollebecque, A.; Friboulet, L.; Lennerz, J. K.; Getz, G.; Juric, D.

Save

KEYNOTE-966: 3-year follow-up for pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) vs placebo (pbo) plus gem/cis for patients (pts) with advanced biliary tract cancer (BTC)

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Ueno, M.; Finn, R. S.; Yoo, C.; Ren, Z.; Furuse, J.; Kelley, R. K.; Chan, S. L.; Edeline, J.; Klumpen, H. J.; Yau, T.; Verslype, C.; Ozaka, M.; Bouattour, M.; Park, J. O.; Vogel, A.; Valle, J. W.; Starkopf, L.; Malhotra, U.; Siegel, A. B.; Qin, S.

Save

Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-11-19

OAAI

Li, Michael; Hannan, Lindsay M.; Goyal, Lipika; Bocobo, Andrea G.; Parks, Anna L.; Bauer, Kelly; Baiev, Islam; Dinicola, Caroline; Gordan, John D.; Venook, Alan P.; Harris, William P.; Bracci, Paige; Kelley, Robin K.

Save

Evidence and choice: The BCLC vision for tailoring clinical decision-making

JOURNAL OF HEPATOLOGY

IF33

2024-10-01

PREAI

Reig, Maria; Forner, Alejandro; Rimola, Jordi; Ferrer-Fabrega, Joana; Burrel, Marta; Garcia-Criado, Angeles; Kelley, Robin K.; Galle, Peter R.; Mazzaferro, Vincenzo; Salem, Riad; Sangro, Bruno; Singal, Amit G.; Vogel, Arndt; Fuster, Josep; Ayuso, Carmen; Bruix, Jordi

Save

COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC

FUTURE ONCOLOGY

IF2.6

2024-06-04

OAAI

Azad, Nilofer; Hu, Zishuo; Sahin, Ilyas; Iyer, Renuka; Aranha, Olivia; Hochster, Howard; Pathak, Priyadarshini; Paulson, Andrew Scott; Kalyan, Aparna; Liao, Chih-Yi; Tran, Nguyen; Kelley, Robin K.; Heestand, Gregory; Cosgrove, David; El-Khoueiry, Anthony; Borad, Mitesh; Gabrail, Nashat Y.; Majeed, Umair; Du, Lingling; Kamath, Suneel; Shumway, Nathan; Shroff, Rachna; Goyal, Lipika; Rosales, Minori; Javle, Milind

Save

68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDG

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2024-05-02

PREAI

Kline, Brad; Yadav, Surekha; Seo, Youngho; Ippisch, Robin Cumming; Castillo, Jessa; Aggarwal, Rahul R.; Kelley, Robin Kate; Behr, Spencer C.; Flavell, Robert R.; Lawhn-Heath, Courtney; Melisko, Michelle; Rugo, Hope S.; Wang, Victoria; Yom, Sue S.; Ha, Patrick; Jiang, Fei; Hope, Thomas A.

Save

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

ANNALS OF ONCOLOGY

IF65.4

2024-05-01

OAAI

Sangro, B.; Chan, S. L.; Kelley, R. K.; Lau, G.; Kudo, M.; Sukeepaisarnjaroen, W.; Yarchoan, M.; De Toni, E. N.; Furuse, J.; Kang, Y. K.; Galle, P. R.; Rimassa, L.; Heurgue, A.; Tam, V. C.; Van Dao, T.; Thungappa, S. C.; Breder, V.; Ostapenko, Y.; Reig, M.; Makowsky, M.; Paskow, M. J.; Gupta, C.; Kurland, J. F.; Negro, A.; Abou-Alfa, G. K.

Save

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study

LANCET GASTROENTEROLOGY & HEPATOLOGY

IF38.6

2024-04-01

PREAI

Yau, Thomas; Kaseb, Ahmed; Cheng, Ann-Lii; Qin, Shukui; Zhu, Andrew X.; Chan, Stephen L.; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Milwee, Steven; Wang, Zhong; Curran, Dominic; Kelley, Robin Kate; Rimassa, Lorenza

Save

Genome-wide association study identifies high-impact susceptibility loci for hepatocellular carcinoma in North America

HEPATOLOGY

IF15.8

2024-02-20

OAAI

Hassan, Manal M.; Li, Donghui; Han, Younghun; Byun, Jinyoung; Hatia, Rikita I.; Long, Erping; Choi, Jiyeon; Kelley, Robin Kate; Cleary, Sean P.; Lok, Anna S.; Bracci, Paige; Permuth, Jennifer B.; Bucur, Roxana; Yuan, Jian-Min; Singal, Amit G.; Jalal, Prasun K.; Ghobrial, R. Mark; Santella, Regina M.; Kono, Yuko; Shah, Dimpy P.; Nguyen, Mindie H.; Liu, Geoffrey; Parikh, Neehar D.; Kim, Richard; Wu, Hui-Chen; El-Serag, Hashem; Chang, Ping; Li, Yanan; Chun, Yun Shin; Lee, Sunyoung S.; Gu, Jian; Hawk, Ernest; Sun, Ryan; Huff, Chad; Rashid, Asif; Amin, Hesham M.; Beretta, Laura; Wolff, Robert A.; Antwi, Samuel O.; Patt, Yehuda; Hwang, Lu-Yu; Klein, Alison P.; Zhang, Karen; Schmidt, Mikayla A.; White, Donna L.; Goss, John A.; Khaderi, Saira A.; Marrero, Jorge A.; Cigarroa, Francisco G.; Shah, Pankil K.; Kaseb, Ahmed O.; Roberts, Lewis R.; Amos, Christopher I.

Save

Research Directions